Clinical Research Directory
Browse clinical research sites, groups, and studies.
the Dutch-GERAF Study
Sponsor: Dijklander Ziekenhuis
Summary
Geriatric patients are at high risk of cardiovascular complications, and for the development of atrial fibrillation. Often atrial fibrillation exists in these patients without specific symptoms, and could therefore remain unknown. Furthermore, concerns exist about the bleeding profile of anticoagulation in the very elderly or frail patients. This study applies opportunistic screening for atrial fibrillation as advised in the latest ESC Guideline on the diagnosis and management of atrial fibrillation. Furthermore, multiple bleeding risk scores will be applies, to better assess the bleeding risk in very elderly or frail patients.
Official title: The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1075
Start Date
2021-01-25
Completion Date
2026-06-30
Last Updated
2024-02-20
Healthy Volunteers
No
Conditions
Interventions
HeartSDK
The photoplethysmography (PPG) application enables patients to perform a finger tip heartbeat measurement and automatic analysis
Locations (6)
Rijnstate
Arnhem, Gelderland, Netherlands
Dijklander Ziekenhuis
Hoorn, North Holland, Netherlands
Noordwest ziekenhuisgroep
Alkmaar, Netherlands
Meander Medisch Centrum
Amersfoort, Netherlands
Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands
Albert Schweitzer Ziekenhuis
Dordrecht, Netherlands